Events
Retreat to Geilo
The whole Centre spent three days together at Geilo, Norway, to present science, discuss strategies and build new collaborations. The program included workshops, poster presentations and pitching, panel- and round table discussions, and project presentations from young scientists and associated PIs. New and experienced skiers could also try the tracks and slopes of Geilo. (Top page photo)
Visiting Professor
Dr. Aaron Newman from Stanford University visited PRIMA for one week in August. Dr. Newman’s research integrates computational and experimental approaches to investigate the cellular organization of complex tissues, with a particular focus on developing innovative data‑science tools that reveal the cellular hierarchies and stromal components driving tumor initiation, progression, and therapeutic response. During his visit, Dr. Newman delivered lectures, provided supervision, and engaged in scientific discussions with researchers both within PRIMA and across the wider scientific community in Oslo.
Breakfast meetings
Our monthly Breakfast Meetings serve as the main gathering point for the Centre, and in 2025 we held nine sessions. Responsibility for the program rotates among the research groups and features a combination of external guest speakers and fundamental science presentations delivered by Centre staff.
Open seminar
In collaboration with PRIMA’s user representatives and their associated patient organizations, we hosted a public seminar titled “Tomorrow’s Precision Immunotherapy for Blood Cancer” at the Radium Hospital. The seminar aimed to share insights into our ongoing research and the development of new immunotherapies targeting blood and lymphatic cancers with patients and the general public. To ensure broad accessibility, the event was also offered digitally, allowing participants to join remotely.
School visit
Photo: Mariia Kotliarova
Biology students from Akademiet Realfagsgymnas Sandvika was on a “field” trip to Olweus’ lab to learn more about biotechnology. They were introduced to basic principles for gene editing and how these methods can be used to create new strategies for cancer therapies.
Seminars/symposia
"mRNA-based therapeutics and cancer-control by cytotoxic T cells" Feb 5
"B cell malignancies, pathogenesis and treatment" June 18
"Decoding Cellular Systems: From Spatial Landscapes to Epigenetic Regulation in Human Health", Aug 28
"Vaccination and humoral immunity", organized in collaboration with the Norwegian Society for Immunology Oct 27
Guest lectures
Marcus Buggert
Assistant Professor, Docent, Karolinska Institutet, Sweden
"Human Memory CD8+ T Cell Cytotoxicity in Health and Correlates to Pan-Cancer Control”
Mustafa Diken
Director Disease Research Center at Translational Oncology Institute (TRON), Mainz, Germany.
“mRNA based therapeutics”
Helene Hallböök
Senior consultant, Associate professor, Dept of Hematology, University Hospital, Sweden
"In search of the optimal treatment for Philadelphia-negative B-ALL, clinical perspectives"
Ingo Ringshausen
Professor, Technical University in Munich, Germany, Associate Professor in Haemato Oncology, University College London, UK
“Oncogenes and tumour microenvironment remodelling in B cell lymphoma”
Evan W. Newell
Professor, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center.
"Profiling human tumor-specific T cell responses for cancer biomarker discovery"
Alexander Fosså
Senior Physician, Department of Oncology, Oslo University Hospital
"Immunterapi med målstyrte celler – behandling fra forskning til dagens praksis"
Aaron Newman
Associate Professor, Department of Biomedical Data Science at Stanford University, and Chan Zuckerberg Biohub Investigator, US.
"Deciphering spatial ecosystems for precision immunotherapy” and "Decoding spatial microenvironments in cancer: tools and perspective"
Roser Vento Tormo
Wellcome Sanger Institute, Cambridge, UK.
"Gene regulation of human cell systems"
Andreas Lundqvist
Professor, Karolinska Institutet, Sweden
"Epigenetic Modulation Drives Inflammatory Responses in Sarcoma"
Jenna Guthmiller
Assistant Professor, Dep. of Immunology & Microbiology, University of Colorado Anschutz School of Medicine, USA.
“Harnessing Humoral Immunity for Next Generation Influenza Vaccines”
Gunnveig Grødeland
Professor, Department of Immunology, Oslo University Hospital, Institute of Clinical Medicine, Centre for Pandemics and One-Health Research, University of Oslo, Norway.
“Vaccination for a diverse population”